Simris Alg AB (OSTO:SIMRIS B) ROCE %: -17.77% (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

OSTO:SIMRIS B Simris Alg AB OSTO:SIMRIS B
19 GF Score
Price kr0.11
GF Value kr0.03
Valuation Significantly Overvalued
! 6 Warning Signs
View Full Analysis

What is Simris Alg AB ROCE %?

Simris Alg AB OSTO:SIMRIS B -5.49% 19 ROCE % is -17.77% as of Mar. 2026. GuruFocus rates OSTO:SIMRIS B with a GF Score™ of 19/100 and a GF Value™ of kr0.03 (Significantly Overvalued). The stock has 6 warning signs investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Simris Alg AB's annualized ROCE % for the quarter that ended in Mar. 2026 was -17.77%.

Simris Alg AB  (OSTO:SIMRIS B) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Simris Alg AB ROCE % Related Terms

Simris Alg AB ROCE % Historical Data

* Premium members only.

The historical data trend for Simris Alg AB's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Simris Alg AB ROCE % Chart

Simris Alg AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
ROCE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -78.93 -27.10 -22.75 -23.02 -21.54

Simris Alg AB Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -21.82 -21.59 -24.31 -28.47 -17.77
OSTO:SIMRIS B
19GF Score
Simris Alg AB OSTO:SIMRIS B
ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Simris Alg AB ROCE % Calculation

Simris Alg AB's annualized ROCE % for the fiscal year that ended in Dec. 2025 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=-28.482/( ( (157.057 - 15.969) + (148.381 - 25.001) )/ 2 )
=-28.482/( (141.088+123.38)/ 2 )
=-28.482/132.234
=-21.54 %

Simris Alg AB's ROCE % of for the quarter that ended in Mar. 2026 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Mar. 2026 )  (Q: Dec. 2025 )(Q: Mar. 2026 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Mar. 2026 )  (Q: Dec. 2025 )(Q: Mar. 2026 )
=-22.504/( ( (148.381 - 25.001) + (142.461 - 12.607) )/ 2 )
=-22.504/( ( 123.38 + 129.854 )/ 2 )
=-22.504/126.617
=-17.77 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of -17.77% mean?
Simris Alg AB (OSTO:SIMRIS B) has a ROCE % of -17.77% as of Mar. 2026.
Is Simris Alg AB's ROCE % too high?
Simris Alg AB's current ROCE % is -17.77%. Overall, Simris Alg AB has a GF Score™ of 19/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Simris Alg AB's ROCE % compare to VRTX and REGN?
Simris Alg AB's ROCE % of -17.77% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Biotechnology company?
A good ROCE % depends on the Biotechnology industry context. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. Simris Alg AB's current ROCE % is -17.77%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Simris Alg AB stock overvalued right now?
Based on GuruFocus' analysis, Simris Alg AB (OSTO:SIMRIS B) is currently considered Significantly Overvalued. The stock's GF Value™ is kr0.03, compared to a current price of kr0.11 — trading 273.3% above its estimated fair value. The current ROCE % is -17.77%. Simris Alg AB's overall GF Score™ is 19/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For Simris Alg AB (OSTO:SIMRIS B), the current ROCE % is -17.77% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Simris Alg AB (OSTO:SIMRIS B) Overvalued in 2026?

Based on GuruFocus' analysis, Simris Alg AB stock appears to be overvalued. The current stock price of kr0.11 is trading 273.3% above its estimated GF Value™ of kr0.03. GuruFocus considers Simris Alg AB to be Significantly Overvalued.

Key valuation signals for OSTO:SIMRIS B:

  • ROCE %: -17.77%
  • GF Value™: kr0.03 vs. price of kr0.11 (273.3% above fair value)
  • GF Score™: 19/100 with 6 warning signs

No single metric tells the full story. See the OSTO:SIMRIS B stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Simris Alg AB Business Description

Other Exchanges 5LU:Germany
Address Herrestadsvagen 24A, Hammenhog, SWE, 276 50
Simris Alg AB is a biotechnology company, engaged in research, development and production of bioactive substances from microalgae, for nutraceutical, cosmeceutical and pharmaceutical applications. The company's technology provides access to bioactive substances with novel functions, while replacing unsustainable raw materials from endangered marine species and ecosystems. Its first commercialised range is a series of omega-3 health supplements marketed under the company's own brand.
19GF Score

Get the complete analysis for OSTO:SIMRIS B

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr0.11
Price
kr0.03
GF Value